Accolade Inc Aktie: Weichen auf Wachstum gestellt! Die Aktionäre von Accolade Inc (ISIN US00437E1029) haben am 27. März 2025 der vorgeschlagenen Fusion mit dem Gesundheitstechnologieunternehmen Transcarent zugestimmt.…
Accolade To Present at Upcoming Investor Conferences SEATTLE, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting…
Accolade Announces Results for Fiscal Second Quarter 2025 SEATTLE, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal…
Accolade to Announce Fiscal Second Quarter 2025 Financial Results SEATTLE, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second…
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating…
Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings NEW YORK, July 14, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating…
Accolade Announces Results for Fiscal First Quarter 2025 SEATTLE, June 27, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal…
Accolade to Announce Fiscal First Quarter 2025 Financial Results SEATTLE, June 12, 2024 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal first…